US Glaucoma Market and Competitive Landscape Highlights - 2016

  • ID: 3679029
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Glaucoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Glaucoma pipeline products, Glaucoma epidemiology, Glaucoma market valuations and forecast, Glaucoma products sales and competitive landscape in the US.

The research is classified into nine sections – Glaucoma overview including etiology, pathophysiology, and diagnosis, Glaucoma treatment options, Glaucoma pipeline products, Glaucoma market analysis comprising of Glaucoma epidemiology, key products marketed for Glaucoma, market valuations and forecast, products sales and market shares.

Research Scope:
- Glaucoma Pipeline: Find out the products in clinical trials for the treatment of Glaucoma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Glaucoma Epidemiology: Find out the number of patients diagnosed (prevalence) with Glaucoma in the US
- Glaucoma Products: Identify key products marketed and prescribed for Glaucoma in the US, including trade name, molecule name, and company
- Glaucoma Product Sales: Find out the sales revenues of Glaucoma products, both branded and generics, in the US
- Glaucoma Market Valuations: Find out the market size for Glaucoma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Glaucoma Products Market Share: Find out the market shares for key Glaucoma products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Glaucoma market analysis and sales trends
- Track competitor drugs sales and market share in the US Glaucoma market
- Track competitive developments in Glaucoma market and present key issues and learnings
- Synthesize insights for Glaucoma market and products to drive business performance
- Answer key business questions about the Glaucoma market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Glaucoma products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Glaucoma Treatments
3) Glaucoma Pipeline
4) US Glaucoma Epidemiology
5) Marketed Drugs for Glaucoma in US
6) US Glaucoma Market Size
7) US Glaucoma Products Sales
8) US Glaucoma Market Competitive Landscape
9) US Glaucoma Market Forecast
10) Methodology
11) Contact us

1. Glaucoma Epidemiology, US, 2010 - 2020
2. Glaucoma Market Size ($), US, 2010 – 2015
3. Glaucoma Products Market Share (%), US, 2015
4. Glaucoma Market Forecast ($), US, 2015 – 2020

1. Glaucoma Phase 3 Clinical Trials, 2016
2. Glaucoma Phase 2 Clinical Trials, 2016
3. Glaucoma Phase 1 Clinical Trials, 2016
4. Glaucoma Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Glaucoma, US, 2016
6. Glaucoma Market Size ($), US, 2010 – 2015
7. Glaucoma Product Sales ($), US, 2010 – 2015
8. Glaucoma Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll